Joel Barker

A well-known drug is being tested to attack Alzheimer’s symptoms

Joel Barker joins Jim Blasingame to report on an existing drug that’s used for other issues, which is being tested to see if it’s properties might reduce the plaque on the brain that causes Alzheimer’s disease.

More interviews with Joel Barker »See all

Thoughts from a futurist
Joel Barker joins Jim Blasingame to share some of the latest in future tech.
Paradigm shift: your next biometric joint may be from a 3-D printer
Joel Barker joins Jim Blasingame to report on how 3D printing is being used in a new method that creates an improved bone joint faster, cheaper and stronger.
New paradigm: converting wind to electric to hydrogen
Joel Barker joins Jim Blasingame to report on a new process that converts wind power into electricity, which is used to produce hydrogen energy, thus addressing the sustainability, transportation and storage of energy.
Paradigm shift: New drug may reverse cognitive decline
Joel Barker joins Jim Blasingame to reveal new understanding of cognitive decline, and a new drug that addresses that new paradigm for mental recovery.
Joel Barker joins Jim Blasingame to report on how 3D printing is being used in a new method that creates an improved bone joint faster, cheaper and stronger.